Inventor

Zhili ZHENG

Inventor

Overview

5→

Patents

2021–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes19%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

C07KPeptides19%

C12NMicroorganisms or enzymes19%

G01NInvestigating or analysing materials by determining their chemical or physical properties19%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology4%

PatentTitleYear

12,391,742Anti-KRAS-G12D T cell receptors2025 11,897,933Anti-KRAS-G12D T cell receptors2024 11,898,207Methods of isolating neoantigen-specific T cell receptor sequences2024 11,840,561Anti-KRAS-G12D T cell receptors2023 11,208,456Anti-KRAS-2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to US HEALTH (5)· patent assignee history

2021–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
US HEALTH	5	2021–2025

Locations

Location	Patents	Span
US	5	2021–2025